Topic
fda-access-program
1 stories related to this topic, newest first.
Science Newsscience8 hrs agoUpdated
Experimental Pill Extended Survival for Advanced Pancreatic Cancer Patients
A daily pill nearly doubled median survival time compared with chemotherapy in a Phase III trial of 500 patients with advanced disease. Researchers presented the results May 31 at the American Society of Clinical Oncology meeting.